Return to content in this issue

 

IgE-mediated Allergy to Pembrolizumab and Successful Desensitization

Torrado I1, Peña MI1,2, Tsopana A1, Mendoza I3, Beitia JM1,2, Mateo B1,2, Chara LE4, Vega A1,2

1Allergy Department, University Hospital of Guadalajara, Spain
2ARADyAL Spanish Thematic Network and Co-operative Research Centre RD16/0006/0023, ISCIII, Madrid, Spain
3Pharmacy Department, University Hospital of Guadalajara, Spain
4Oncology Department, University Hospital of Guadalajara, Spain

J Investig Allergol Clin Immunol 2023; Vol 33(4) : 304-306
doi: 10.18176/jiaci.0858

Key words: Pembrolizumab, Allergy, Desensitization, Lung cancer, Anti-PD-1 antibody